GILD - Gilead Sciences Inc. (GILD) Barclays 26th Annual Global Healthcare Conference (Transcript)
2024-03-13 15:52:06 ET
Gilead Sciences, Inc. (GILD)
Barclays 26th Annual Global Healthcare Conference
March 13, 2024 11:15 AM ET
Company Participants
Andy Dickinson - CFO
Conference Call Participants
Carter Gould - Barclays
Presentation
Carter Gould
Good afternoon. Welcome to Day 2 of the Barclays Global Healthcare Conference. My name is Carter Gould, covering U.S. biopharma. I am pleased to welcome Gilead Sciences to the stage.
Joining us from the company, Andy Dickinson, CFO. Andy, you’re going to make some opening comments, and then we'll launch in the Q&A.
Andy Dickinson
Great. Thanks. Thank you for having us, and thanks for joining the presentation. Look, at a high level, I'd say it's an exciting period for Gilead. We're moving into kind of the second stage of the restructuring expansion of the company. We have a number of growth opportunities and we expect accelerating growth through the end of the decade. So as most of you know, we have the world's largest HIV business, stable, growing long-term patent protection and a number of product launches that are coming between now and the end of the decade that should drive additional growth....
Gilead Sciences, Inc. (GILD) Barclays 26th Annual Global Healthcare Conference (Transcript)